Hasil Pencarian - Lucio Catalano

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Two-dimensional kinematics in gait evaluation of Bardigiano Horse breeding stock

    Two-dimensional kinematics in gait evaluation of Bardigiano Horse breeding stock oleh Antonio Lucio Catalano, Francesca Martuzzi, Franca Vaccari Simonini, Stefano Gosi, Alessia Ranieri

    Diterbitkan 2010-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma

    Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma oleh Claudio Cerchione, Davide Nappi, Maria Di Perna, Irene Zacheo, Anna Emanuele Pareto, Marco Picardi, Lucio Catalano, Fabrizio Pane

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Strategy for the treatment and follow-up of sinonasal solitary extramedullary plasmacytoma: a case series

    Strategy for the treatment and follow-up of sinonasal solitary extramedullary plasmacytoma: a case series oleh Elena Cantone, Antonella Miriam Di Lullo, Luana Marano, Elia Guadagno, Gelsomina Mansueto, Pasquale Capriglione, Lucio Catalano, Maurizio Iengo

    Diterbitkan 2017-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    An NMR Study of the Bortezomib Degradation under Clinical Use Conditions

    An NMR Study of the Bortezomib Degradation under Clinical Use Conditions oleh Adele Bolognese, Anna Esposito, Michele Manfra, Lucio Catalano, Fara Petruzziello, Maria Carmen Martorelli, Raffaella Pagliuca, Vittoria Mazzarelli, Maria Ottiero, Melania Scalfaro, Bruno Rotoli

    Diterbitkan 2009-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience

    Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience oleh Rossella Iula, Danilo De Novellis, Danilo De Novellis, Fabio Trastulli, Roberta Della Pepa, Raffaele Fontana, Angela Carobene, Maria Di Perna, Alessandro D’Ambrosio, Martina Romano, Aldo Leone, Laura De Fazio, Alfonso Fiumarella, Giuseppe Gaeta, Violetta Marafioti, Serafina Barbato, Salvatore Palmieri, Stefano Rocco, Bianca Serio, Catello Califano, Fabrizio Pane, Felicetto Ferrara, Valentina Giudice, Valentina Giudice, Carmine Selleri, Carmine Selleri, Lucio Catalano

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials

    Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage T... oleh Fortunato Morabito, Fortunato Morabito, Elena Zamagni, Elena Zamagni, Concetta Conticello, Vincenzo Pavone, Salvatore Palmieri, Sara Bringhen, Monica Galli, Silvia Mangiacavalli, Daniele Derudas, Elena Rossi, Roberto Ria, Lucio Catalano, Paola Tacchetti, Giuseppe Mele, Iolanda Donatella Vincelli, Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Francesco Mendicino, Cirino Botta, Anna Mele, Lucia Pantani, Serena Rocchi, Serena Rocchi, Bruno Garibaldi, Nicola Cascavilla, Stelvio Ballanti, Giovanni Tripepi, Ferdinando Frigeri, Antonetta Pia Falcone, Clotilde Cangialosi, Giovanni Reddiconto, Giuliana Farina, Marialucia Barone, Ilaria Rizzello, Ilaria Rizzello, Enrico Iaccino, Selena Mimmi, Paola Curci, Barbara Gamberi, Pellegrino Musto, Valerio De Stefano, Maurizio Musso, Maria Teresa Petrucci, Massimo Offidani, Francesco Di Raimondo, Mario Boccadoro, Michele Cavo, Michele Cavo, Antonino Neri, Massimo Gentile

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: